Skip to content
Tuesday, November 10, 2026
Bonus Lounge

Individuals Stopping Anti-Obesity Medications Gain Back Weight at a Quadrupled Rate Compared to People Using Diet and Exercise

Image of pharmaceutical syringe and scale
Obesity treatment often requires long-term strategies.

A recent study indicates that people who stop using blockbuster GLP-1 drugs like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who stop traditional diet and exercise plans.

Research printed in a major medical journal points out that while overweight people frequently drop substantial amounts of their body weight while using the jabs, the weight is regained at an average rate of 0.8 kg per month once they quit.

"People using such medications should be informed of the risk of quick weight regain when the therapy concludes," cautioned researcher Dr. Susan Jebb.

Such speed of recovery implies a return to starting weight within about one and a half years.

Weighing Treatments

The study, which reviewed 37 of trials involving over 9,000 of participants, contrasted the effects of the injectable medications with other pills.

Scientists emphasize that people who lose weight through lifestyle changes alone generally have a slower weight regain—perhaps 100 grams monthly—after stopping.

Understanding the Quick Rebound

Nutrition scientists believe the way of the jabs explains the accelerated regain.

The injections mimic a natural hormone called GLP-1, which moderates hunger.

"Sustained high doses of the hormone levels several times higher than the body's typical production might result in the body to produce less of its endogenous GLP-1, and could reduce responsiveness to its effects," explained Dr. Adam Collins, a dietetics researcher.

"Withdrawal of this GLP-1 'fix' means appetite is no longer kept in check, making binge eating much more probable."

A Chronic Disease?

The NHS suggest the injections for people with obesity-related medical conditions, accompanied by recommended lifestyle changes.

A number of clinicians argue that, considering the significant potential of relapse, the therapy might need to be life-long.

This opinion is supported by drug manufacturers, who note that the results "underscore the long-term nature of obesity," akin to managing conditions like high blood pressure.

Patient Experiences

Users who have come off the medication report a sudden return of appetite.

"It was like a switch flipping and you're instantly extremely hungry," said a patient.

The struggle is worsened if patients have not developed sustainable dietary or behavioural modifications during treatment.

Significant Interest

Survey data show that a significant number of adults in the UK have used these injections in the last 12 months, with demand continuing to grow.

  • Adoption is higher among females compared to males.
  • The middle-aged demographic shows the highest usage rates.
  • Many obtain the drugs through private prescriptions rather than the NHS.

Ultimately, researchers emphasize that while the jabs are effective agents for shedding pounds, they are not a magic fix and long-term success hinges on ongoing behavioural changes.

GL
Written by

Grace Lee

A seasoned gaming analyst with over a decade of experience in the UK casino industry, specializing in bonus strategies and player insights.

Bonus Lounge

Type to search articles.